Rebif offers another option for treating multiple sclerosis.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	889-891
Number of pages	3
Journal	Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Volume	42
Issue number	6
DOIs	https://doi.org/10.1331/108658002762063772
State	Published - 2002

ASJC Scopus subject areas

TY - JOUR

T1 - Rebif offers another option for treating multiple sclerosis.

AU - Ryan, Melody

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036832261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036832261&partnerID=8YFLogxK

U2 - 10.1331/108658002762063772

DO - 10.1331/108658002762063772

M3 - Article

C2 - 12482017

AN - SCOPUS:0036832261

SN - 1086-5802

VL - 42

SP - 889

EP - 891

JO - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

JF - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

IS - 6

ER -